Stablecoin Development Corp 10-Q, filed May 12, 2010: EXHIBIT 32.2
EXHIBIT 32.2
CERTIFICATION
PURSUANT TO
18
U.S.C. §1350,
AS
ADOPTED PURSUANT TO
SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
In
connection with the Quarterly Report of NovaBay Pharmaceuticals, Inc. (the
“Company”) on Form 10-Q for the quarter ended March 31, 2010 as filed with the
Securities and Exchange Commission on the date hereof (the “Report”), I, Thomas
J. Paulson, Chief Financial Officer of the Company, certify, pursuant to 18
U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act
of 2002, that:
1. The
Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and
2. The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.
Date: May
12, 2010
|
/s/
Thomas J. Paulson
|
|
Thomas
J. Paulson
|
|
Chief
Financial Officer
|
49